David Geldmacher, MD, professor of neurology and director of the Division of Memory Disorders and Behavioral Neurology at the University of Alabama at Birmingham.
Although there are some approved medications for Alzheimer’s disease (AD), nothing has ever been able to slow down the relentless progression of the disease until...
